UnknownNot applicableNCT03195049

Complications of Exchange Transfusion in Neonates

Studying Bilirubin encephalopathy

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assiut University
Principal Investigator: Hanaa Ab Mohamed, Professor
Assiut University
Intervention: blood group,complete blood count(diagnostic_test)
Enrollment: 50 enrolled
Eligibility: All sexes
Timeline: 2018 – 2019

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03195049 on ClinicalTrials.gov

Other trials for Bilirubin encephalopathy

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGPHASE2NCT04584983
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
The University of Texas Health Science Center, Houston

See all trials for Bilirubin encephalopathy →

← Back to all trials